These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hyperhomocysteinemia and thrombosis. Lee R; Frenkel EP Hematol Oncol Clin North Am; 2003 Feb; 17(1):85-102. PubMed ID: 12627664 [TBL] [Abstract][Full Text] [Related]
24. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study. Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D; Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889 [TBL] [Abstract][Full Text] [Related]
25. The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects. Lijfering WM; Coppens M; van de Poel MH; Middeldorp S; Hamulyák K; Bank I; Veeger NJ; Prins MH; Büller HR; van der Meer J Thromb Haemost; 2007 Aug; 98(2):457-63. PubMed ID: 17721631 [TBL] [Abstract][Full Text] [Related]
26. Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects. Vayá A; Gómez I; Mira Y; Ferrando F; Corella D Thromb Haemost; 2008 Jun; 99(6):1132-4. PubMed ID: 18521525 [No Abstract] [Full Text] [Related]
28. No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study. Keijzer MB; Borm GF; Blom HJ; Bos GM; Rosendaal FR; den Heijer M Thromb Haemost; 2007 Jan; 97(1):32-7. PubMed ID: 17200768 [TBL] [Abstract][Full Text] [Related]
29. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740 [TBL] [Abstract][Full Text] [Related]
30. Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Peyrin-Biroulet L; Rodriguez-Guéant RM; Chamaillard M; Desreumaux P; Xia B; Bronowicki JP; Bigard MA; Guéant JL Am J Gastroenterol; 2007 May; 102(5):1108-15. PubMed ID: 17355415 [TBL] [Abstract][Full Text] [Related]
31. Diabetes mellitus and hyperhomocysteinemia. van Guldener C; Stehouwer CD Semin Vasc Med; 2002 Feb; 2(1):87-95. PubMed ID: 16222599 [TBL] [Abstract][Full Text] [Related]
32. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms. Zhou J; Austin RC Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439 [TBL] [Abstract][Full Text] [Related]
34. Low fasting methionine concentration as a novel risk factor for recurrent venous thrombosis. Keijzer MB; den Heijer M; Borm GF; Blom HJ; Vollset SE; Hermus AR; Ueland PM Thromb Haemost; 2006 Oct; 96(4):492-7. PubMed ID: 17003928 [TBL] [Abstract][Full Text] [Related]
35. Association of homocysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss. Nadir Y; Hoffman R; Brenner B Ann Hematol; 2007 Jan; 86(1):35-40. PubMed ID: 17043779 [TBL] [Abstract][Full Text] [Related]
36. Proceedings of the Fourth Conference on Hyperhomocysteinemia. Saarbrücken, Germany. April 14-16, 2005. Clin Chem Lab Med; 2005; 43(10):977-1169. PubMed ID: 16320456 [No Abstract] [Full Text] [Related]
38. Pilot study of homocysteine and cysteine in patients with thrombosis in different vascular sites. Epidemiology and response to folate. Casais P; Alberto MF; Salviú MJ; Meschengieser SS; Aixalá M; Lazzari MA Thromb Res; 2009 Feb; 123(4):592-6. PubMed ID: 18511109 [TBL] [Abstract][Full Text] [Related]